Anixa Biosciences and OntoChem Have Synthesized Four Potential Covid-19 Drugs for Testing in Biological Assays
Retrieved on:
Monday, June 1, 2020
Anixa and OntoChem announced their partnership on April 20, 2020 ( https://ir.anixa.com/press-releases/detail/947/ ) and announced discovery of its first potential Covid-19 candidate two weeks later on May 4, 2020.
Key Points:
- Anixa and OntoChem announced their partnership on April 20, 2020 ( https://ir.anixa.com/press-releases/detail/947/ ) and announced discovery of its first potential Covid-19 candidate two weeks later on May 4, 2020.
- As the computer-based screening identified potential compounds, they would be synthesized and tested in biological assays to evaluate their potency as predicted by the molecular modeling algorithms.
- Should the biological activity be verified, the compounds will be tested in animal studies to further evaluate their candidacy as Covid-19 therapeutics.
- These compounds have been synthesized and we are now engaged in testing these compounds in biological assays to verify the efficacy that was predicted in silico."